Visit COVID-19 resources

[Skip to Content]

Intraocular xanthomatous tumor presenting as fulminant uveitis – (Eye 29, 296 (February 2015))

Mar 05
2015

Intraocular xanthomatous tumor presenting as fulminant uveitis Eye 29, 296 (February 2015). doi:10.1038/eye.2014.287 Authors: C-Y Cheng, P-Y Chen & C-J Lin

  • 5 March 2015

The cerebellum in eye movement control: nystagmus, coordinate frames and disconjugacy – (Eye 29, 299 (February 2015))

Mar 05
2015

The cerebellum in eye movement control: nystagmus, coordinate frames and disconjugacy Eye 29, 299 (February 2015). doi:10.1038/eye.2014.306 Authors: V R Patel & D S Zee

  • 5 March 2015

Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population – (Eye 29, 300 (February 2015))

Mar 05
2015

Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population Eye 29, 300 (February 2015). doi:10.1038/eye.2014.307 Authors: B Diniz, D C Rodger, V R Chavali, T MacKay, S Y Lee, D Stambolian & S V R Sadda

  • 5 March 2015

Choroidal thickness in regressed retinopathy of prematurity – (Eye 28, 1461 (December 2014))

Dec 11
2014

Choroidal thickness in regressed retinopathy of prematurity Eye 28, 1461 (December 2014). doi:10.1038/eye.2014.207 Authors: M F Anderson, B Ramasamy, D T Lythgoe & D Clark

  • 11 December 2014

Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome – (Eye 28, 1469 (December 2014))

Dec 11
2014

Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome Eye 28, 1469 (December 2014). doi:10.1038/eye.2014.222 Authors: M Ho, E C F Lo, A L Young & D T L Liu

  • 11 December 2014